Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 201–300 of 999

Effect of Homocysteine-Lowering Nutrients on Blood Lipids: Results from Four Randomised, Placebo-Controlled Studies in Healthy Humans
Olthof, M. R., van Vliet, T., Verhoef, P., Zock, P. L., & Katan, M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020135 · Cited by 101
Predominance of Large LDL and Reduced HDL 2 Cholesterol in Normolipidemic Men With Coronary Artery Disease
Campos, H., Roederer, G. O., Lussier‐Cacan, S., Davignon, J., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1043 · Cited by 101
Effects of the Luteinizing Hormone-Releasing Hormone Agonist Leuprolide on Lipoproteins, Fibrinogen and Plasminogen Activator Inhibitor in Patients with Benign Prostatic Hyperplasia
Eri, L. M., Urdal, P., & Bechensteen, A. G. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67239-2 · Cited by 100
Health implications of Mediterranean diets in light of contemporary knowledge. 2. Meat, wine, fats, and oils
Kushi, L. H., Lenart, E., & Willett, W. C. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1416s · Cited by 101
Self-citation
Alcohol and Lipids
Baraona, E., & Lieber, C. S. (1998) · Springer eBooks · doi:10.1007/0-306-47148-5_5 · Cited by 101
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99
Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.
Sweetnam, P. M., Bolton, C. H., Yarnell, J. W., Bainton, D., Baker, I. A., Elwood, P. C., & Miller, N. E. (1994) · Circulation · doi:10.1161/01.cir.90.2.769 · Cited by 98
Prevalencia y características de la dislipemia en pacientes en prevención primaria y secundaria tratados con estatinas en España. Estudio DYSIS-España
González‐Juanatey, J. R., Millán, J., Alegría, E., Guijarro, C., Lozano, J. V., & Vitale, G. C. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.030 · Cited by 99
Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians
Salvini, S., Hennekens, C. H., Morris, J. S., Willett, W. C., & Stampfer, M. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80344-0 · Cited by 98
Self-citation
Effect of Alcohol on Lipids and Lipoproteins in Relation to Atherosclerosis
Hannuksela, M. L., Liisanantti, M. K., & Savolainen, M. J. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795529 · Cited by 97
Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?
Parodi, P. W. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.01.001 · Cited by 99
Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians
Hak, A. E., Stampfer, M. J., Campos, H., Sesso, H. D., Gaziano, J. M., Willett, W. C., & Ma, J. (2003) · Circulation · doi:10.1161/01.cir.0000084546.82738.89 · Cited by 96
Self-citation
Lipoproteins, nutrition, aging, and atherosclerosis
Schaefer, E. J., Lichtenstein, A. H., Lamon‐Fava, S., McNamara, J., & Ordovás, J. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.726s · Cited by 96
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
Nanjee, M. N., Crouse, J. R., King, J. M., Hovorka, R., Rees, S. E., Carson, E. R., Morgenthaler, J. ‐., Lerch, P., & Miller, N. E. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1203 · Cited by 96
Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease
Zhang, X., Zhao, S., Li, X.-P., Gao, M., & Zhou, Q. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00288-9 · Cited by 96
Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E–Deficient Mice
Geest, B. D., Zhao, Z., Collen, D., & Holvoet, P. (1997) · Circulation · doi:10.1161/01.cir.96.12.4349 · Cited by 96
Diet and Coronary Heart Disease
Willett, W. C., & Stampfer, M. J. (2012) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199754038.003.0019 · Cited by 94
Self-citation
Dyslipidaemia in Rheumatological Autoimmune Diseases
Toms, T. E., Panoulas, V. F., & Kitas, G. D. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010064 · Cited by 95
Role of Niacin in Current Clinical Practice: A Systematic Review
Garg, A., Sharma, A., Krishnamoorthy, P. M., Garg, J., Virmani, D., Sharma, T., Stefanini, G. G., Kostis, J. B., Mukherjee, D., & Sikorskaya, E. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.07.038 · Cited by 95
Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome
Church, T., Finley, C., Earnest, C. P., Kampert, J. B., Gibbons, L., & Blair, S. N. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802001 · Cited by 95
The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice.
Marotti, K. R., Castle, C. K., Murray, R. W., Rehberg, E. F., Polites, H. G., & Melchior, G. W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.736 · Cited by 67
A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians
Güallar, E., Hennekens, C. H., Sacks, F. M., Willett, W. C., & Stampfer, M. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00370-6 · Cited by 94
Self-citation
High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program
Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Chen, R., Popper, J. S., Petrovitch, H., Ross, G. W., Schatz, I. J., Belleau, G. C., et al. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh177 · Cited by 93
High-Density Lipoprotein As a Therapeutic Target: Clinical Evidence and Treatment Strategies
Toth, P. P. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.008 · Cited by 91
Alcohol and cardiovascular disease
Rimm, E. B. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0054-8 · Cited by 92
Preserved Endothelial Function in Patients With Severe Hypertriglyceridemia and Low Functional Lipoprotein Lipase Activity
Chowienczyk, P., Watts, G. F., Wierzbicki, A. S., Cockcroft, J. R., Brett, S., & Ritter, J. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00033-8 · Cited by 92
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Hilbrands, L. B., Demacker, P. N. M., Hoitsma, A. J., Stalenhoef, A. F. H., & Koene, R. A. P. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122073 · Cited by 91
Coronary bypass surgery should not be offered to smokers.
Underwood, M. J., & Bailey, J. (1993) · BMJ · doi:10.1136/bmj.306.6884.1047 · Cited by 91
Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol.
Clifton, P. M., & Nestel, P. J. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.955 · Cited by 91
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (≤60 years) with coronary artery disease
Kwiterovich, P. O., Coresh, J., & Bachorik, P. S. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91002-y · Cited by 91
Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort
Williams, P. T., & Feldman, D. E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.024 · Cited by 90
Risk factors for coronary heart disease in patients with spinal cord injury in Turkey
Demirel, Ş., Demirel, G. ⁄. L., Tükek, T., Erk, O., & Yılmaz, H. G. (2001) · Spinal Cord · doi:10.1038/sj.sc.3101135 · Cited by 90
Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.
Mowri, H., Patsch, W., Smith, L., Gotto, A. M., & Patsch, J. R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40541-3 · Cited by 89
Severe Obesity: Effects on Foot Mechanics During Walking
Messier, S. P., Davies, A. B., Moore, D., Davis, S. E., Pack, R. J., & Kazmar, S. C. (1994) · Foot & Ankle International · doi:10.1177/107110079401500106 · Cited by 89
Lipid and lipoprotein measurements and the risk of ischemic vascular events
Pikula, A., Beiser, A., Wang, J., Himali, J. J., Kelly‐Hayes, M., Kase, C. S., Yang, Q., Seshadri, S. S., & Wolf, P. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001202 · Cited by 90
Influence of baseline lipids on effectiveness of pravastatin in the CARE trial
Pfeffer, M. A., Sacks, F. M., Moyé, L. A., East, C. A., Goldman, S. M., Nash, D. T., Rouleau, J. R., Rouleau, J. L., Sussex, B. A., Théroux, P., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00522-1 · Cited by 89
Self-citation
Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies
Richter, W. O., Jacob, B. G., Ritter, M. M., Sühler, K., Vierneisel, K., & SCHWANDT, P. (1993) · Metabolism · doi:10.1016/0026-0495(93)90065-v · Cited by 89
Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency
Marcil, M., Yu, L., Krimbou, L., Boucher, B., Oram, J. F., Cohn, J. S., & Genest, J. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.159 · Cited by 89
High-density lipoprotein subfractions
Silverman, D. I., Ginsburg, G. S., & Pasternak, R. C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90217-d · Cited by 88
Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies
Joshi, P. H., Toth, P. P., Lirette, S. T., Griswold, M. E., Massaro, J. M., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Khokhar, A. A., Correa, A., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314543890 · Cited by 91
Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit
Nielsen, J. V., Gando, C., Joensson, E., & Paulsson, C. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-23 · Cited by 89
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men
Bremner, W. F., Sothern, R. B., Kanabrocki, E. L., Ryan, M. D., McCormick, J. B., Dawson, S. D., Connors, E. S., Rothschild, R., Third, J. L. H. C., Vahed, S., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90324-7 · Cited by 88
DIET AND HEART DISEASE
Gaziano, J. M., & Manson, J. E. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70261-7 · Cited by 88
Alcohol and Dementia – What is the Link? A Systematic Review
Wiegmann, C., Mick, I., Brandl, E. J., Heinz, A., & Gutwinski, S. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198772 · Cited by 90
Lipid Profile Components and Risk of Ischemic Stroke
Willey, J. Z., Xu, Q., Boden-Albala, B. M., Paik, M. C., Moon, Y. P., Sacco, R. L., & Elkind, M. S. V. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.210 · Cited by 87
Dyslipidaemia and rheumatoid arthritis
Situnayake, R. D., & Kitas, G. D. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.341 · Cited by 87
High density lipoprotein cholesterol in individuals with spinal cord injury: The potential role of physical activity
Ra, W., & Sf, F. (1999) · Spinal Cord · doi:10.1038/sj.sc.3100917 · Cited by 86
In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch, J., Julius, U., Nitzsche, S., & Markolf Hanefeld, E. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1928 · Cited by 86
Subfractions and Subpopulations of HDL: An Update
Rizzo, M., Otvos, J. D., Nikolić, D., Montalto, G., Toth, P. P., & Banach, M. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140414103455 · Cited by 84
The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer
McGrowder, D. A., Riley, C. K., Morrison, E., & Gordon, L. (2010) · Cholesterol · doi:10.1155/2011/496925 · Cited by 85
Progressing Insights into the Role of Dietary Fats in the Prevention of Cardiovascular Disease
Zock, P. L., Blom, W. A. M., Nettleton, J. A., & Hornstra, G. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0793-y · Cited by 85
Invited Commentary--Alcohol Consumption and Coronary Heart Disease: Good Habits May Be More Important Than Just Good Wine
Rimm, E. B. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008684 · Cited by 80
A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men
Liu, S., Schmitz, C., Stampfer, M. J., Sacks, F. M., Hennekens, C. H., Lindpaintner, K., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00673-6 · Cited by 82
Self-citation
Beyond the rodent model: Calorie restriction in rhesus monkeys
Lane, M. A., Ingram, D. K., & Roth, G. S. (1997) · AGE · doi:10.1007/s11357-997-0004-2 · Cited by 81
Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia
Johansson, J., OLSSON, A. G., Bergstrand, L., Elinder, L. S., Nilsson, S., Erikson, U., Mölgaard, J., Holme, I., & Walldius, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1049 · Cited by 80
Utility of Non–High-Density Lipoprotein Cholesterol Versus Other Lipoprotein Measures in Detecting Subclinical Atherosclerosis in Young Adults (The Bogalusa Heart Study)
Frontini, M., Srinivasan, S. R., Xu, J.-H., Tang, R., Bond, M. G., & Berenson, G. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.071 · Cited by 80
High Density Lipoproteins in Health and in Disease
Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80
Severity of Liver Injury and Atherogenic Lipid Profile in Children With Nonalcoholic Fatty Liver Disease
Nobili, V., Alkhouri, N., Bartuli, A., Manco, M., López, R., Alisi, A., & Feldstein, A. E. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181da4798 · Cited by 79
High-Density Lipoprotein Metabolism: Potential Therapeutic Targets
Davidson, M. H., & Toth, P. P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.011 · Cited by 79
Dose–response effect of walking exercise on weight loss. How much is enough?
Brill, J. B., Perry, A., Parker, L., Robinson, A. H., & Burnett, K. F. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802133 · Cited by 79
Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects
Bruseghini, P., Calabria, E., Tam, E., Milanese, C., Oliboni, E. S., Pezzato, A., Pogliaghi, S., Salvagno, G. L., Schena, F. F., Mucelli, R. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4031 · Cited by 83
Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
Marshall, H. W., Morrison, L. C., Wu, L., Anderson, J. L., Corneli, P. S., Stauffer, D. M., Allen, A., Karagounis, L. A., & Ward, R. H. (1994) · Circulation · doi:10.1161/01.cir.89.2.567 · Cited by 78
Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites
Kamboh, M. I., Aston, C. E., Ferrell, R. E., & Hamman, R. F. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90129-i · Cited by 78
Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease
Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L., Chiu, D., Rodríguez, B. L., Curb, J. D., & Sharp, D. S. (1995) · Circulation · doi:10.1161/01.cir.92.6.1430 · Cited by 78
Perfluoroalkyl Substances During Pregnancy and Validated Preeclampsia Among Nulliparous Women in the Norwegian Mother and Child Cohort Study
Starling, A. P., Engel, S. M., Richardson, D. B., Baird, D. D., Haug, L. S., Stuebe, A. M., Klungsøyr, K., Harmon, Q. E., Becher, G., Thomsen, C., et al. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt432 · Cited by 81
High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort
McGarrah, R. W., Craig, D. M., Haynes, C. S., Dowdy, Z. E., Shah, S. H., & Kraus, W. E. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.012 · Cited by 77
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women
Clevidence, B. A., Reichman, M. E., Judd, J. T., Muesing, R. A., Schatzkin, A. G., Schaefer, E. J., Li, Z., Jenner, J. L., Brown, C., Sunkin, M. E., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.179 · Cited by 77
Quantum Dot and Cy5.5 Labeled Nanoparticles to Investigate Lipoprotein Biointeractions via Förster Resonance Energy Transfer
Skajaa, T., Zhao, Y., van den Heuvel, D. J., Gerritsen, H. C., Cormode, D. P., Koole, R., van Schooneveld, M. M., Post, J. A., Fisher, E. A., Fayad, Z. A., et al. (2010) · Nano Letters · doi:10.1021/nl1037903 · Cited by 76
Extended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder
Weisler, R. H., Hirschfeld, R. M. A., Cutler, A. J., Gazda, T. D., Ketter, T. A., Keck, P. E., Swann, A., & Kalali, A. H. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00004 · Cited by 76
Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans
Maeda, S., Nakanishi, S., Yoneda, M., Awaya, T., Yamane, K., Hirano, T., & Kohno, N. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11445 · Cited by 76
Coronary heart disease risk indicators, aerobic power, and physical activity in men with spinal cord injuries
Janssen, T. W. J., van OERS, C. A. J. M., van Kamp, G. J., ten Voorde, B. J., van der Woude, L. H. V., & Hollander, A. P. (1997) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(97)90076-9 · Cited by 76
Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study
Talmud, P. J., Ye, S., Humphries, S. E., & On Behalf of The Ears Group (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110305 · Cited by 76
The new pathophysiology of coronary artery disease
Castelli, W. P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00729-2 · Cited by 76
Beneficial Effects of Testosterone Undecanoate on the Lipoprotein Profiles in Healthy Elderly Men. A Placebo Controlled Study.
UYANIK, B. S., ARI, Z., GÜMÜS, B., YIGITOGLU, M. R., & ARSLAN, T. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.73 · Cited by 75
Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China
Wang, H., Chen, Y., Guo, X., Chang, Y., & Sun, Y. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1375714 · Cited by 75
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
Liang, J.-S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., & Sipe, J. D. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37293-x · Cited by 75
Low High-Density Lipoprotein Cholesterol
Hersberger, M., & von Eckardstein, A. (2003) · Drugs · doi:10.2165/00003495-200363180-00003 · Cited by 74
Elevated Lipoprotein(a)—A Genetic Risk Factor for Premature Vascular Disease in People With and Without Standard Risk Factors: A Review
Enas, E. A., Chacko, V., Senthilkumar, A., Puthumana, N., & Mohan, V. (2006) · Disease-a-Month · doi:10.1016/j.disamonth.2006.01.002 · Cited by 75
Residence in mountainous compared with lowland areas in relation to total and coronary mortality. A study in rural Greece
Baibas, N., Trichopoulou, A., Voridis, E., & Trichopoulos, D. (2005) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2004.025510 · Cited by 74
Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population
Wang, T., Chen, W., Chien, K., Su, S., Hsu, H., Chen, M.-F., Liau, C., & Lee, Y. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01843-4 · Cited by 72
Interrelationships among Lipoprotein Levels, Sex Hormones, Anthropometric Parameters, and Age in Hypogonadal Men Treated for 1 Year with a Permeation-Enhanced Testosterone Transdermal System1
Dobs, A. S., Bachorik, P. S., Arver, S., Meikle, A. W., Sanders, S. W., Caramelli, K. E., & Mazer, N. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7285 · Cited by 73
Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins
Panzenboeck, U., & Stocker, R. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.003 · Cited by 73
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects
Berglund, L., Oliver, E. H., Fontanez, N., Holleran, S., Matthews, K. A., Roheim, P. S., Ginsberg, H. N., Ramakrishnan, R., & LeFevre, M. L. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.992 · Cited by 71
The Effect of a High-Intensity Interval Training Program on High-Density Lipoprotein Cholesterol in Young Men
Musa, D. I., ADENIRAN, S. A., Dikko, A. A. U., & Sayers, S. P. (2009) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e318198fd28 · Cited by 73
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease
Peloso, G. M., Demissie, S., Collins, D. E., Mirel, D. B., Gabriel, S., Cupples, L. A., Robins, S. J., Schaefer, E. J., & Brousseau, M. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p008268 · Cited by 71
Alcohol in the Mediterranean diet
Rimm, E. B., & Ellison, R. C. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1378s · Cited by 71
PASSCLAIM - Diet-related cardiovascular disease
Mensink, R. P., Aro, A., Hond, E. D., German, J. B., Griffin, B. A., ten Meer, H.-U., Mutanen, M. L., Pannemans, D. L. E., & Stahl, W. (2003) · European Journal of Nutrition · doi:10.1007/s00394-003-1102-2 · Cited by 72
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost
Goldman, L., Phillips, K. A., Coxson, P. G., Goldman, P. A., Williams, L. W., Hunink, M. G. M., & Weinstein, M. C. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01512-1 · Cited by 72
Plasma cholesteryl ester transfer protein and high‐density lipoproteins: new insights from molecular genetic studies
Tall, A. R. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01133.x · Cited by 70
Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome
Mansoub, S., Chan, M. K., & Adeli, K. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.02.013 · Cited by 70
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction
Seeger, J. D., Walker, A. M., Williams, P. L., Saperia, G. M., & Sacks, F. M. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.057 · Cited by 70
Self-citation
Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men.
Dobiášová, M., Stříbrná, J., Pritchard, P., & Frohlich, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41395-1 · Cited by 70
The complexity of HDL
Francis, G. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.009 · Cited by 69
Extended-release niacin for modifying the lipoprotein profile
Guyton, J. R. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1385 · Cited by 71
Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study
Srinivasan, S. R., & Berenson, G. S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.159 · Cited by 68
The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease
O’Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D. O., Bailey, K. R., Holmes, D. R., & Kottke, B. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.228 · Cited by 69
Familial lipoprotein disorders and premature coronary artery disease
Schaefer, E. J., Genest, J. J., Ordovás, J. M., Salem, D. N., & Wilson, P. W. F. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90152-x · Cited by 68
Role of lipid and lipoprotein profiles in risk assessment and therapy
Ballantyne, C. M., & Hoogeveen, R. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94701-0 · Cited by 68
Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: Functional correlation with lecithin : cholesterol acyltransferase
Ohta, T., Nakamura, R., Ikeda, Y., Shinohara, M., Miyazaki, A., Horiuchi, S., & Matsuda, I. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90083-8 · Cited by 68
Effects of Diet on High-Density Lipoprotein Cholesterol
Siri‐Tarino, P. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0207-y · Cited by 70

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks